Načítá se...
Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19
The emergence and global spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has resulted in an urgent need for evidence on medical interventions and outcomes of the resulting disease, coronavirus disease 2019 (COVID‐19). Although many randomized controlled trials (RCTs) evalu...
Uloženo v:
| Vydáno v: | Clin Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8014840/ https://ncbi.nlm.nih.gov/pubmed/33529354 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.2185 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|